长江生命科技(00775.HK) 发盈警,与上年度溢利1,730万元相比,预计2024年度录得亏损约1.27亿元。盈转亏主要因公司决意增加研发投资,以及葡萄园组合的公平值下降。(de/d)(港股报价延迟最少十五分钟。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/13 | 中期业绩 | 无派息 |
2024/03/19 | 末期业绩 | 无派息 |
2023/08/01 | 中期业绩 | 无派息 |
2023/03/14 | 末期业绩 | 股息:港元 0.0080 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.